Trial Profile
Safety and Immunogenecity Study of an E.Coli Expressed Particulate Recombinant Hepatitis E Vaccine
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Recombinant hepatitis E vaccine (Hecolin) (Primary) ; Aluminium hydroxide; Hepatitis B vaccine recombinant
- Indications Hepatitis B; Hepatitis E
- Focus Pharmacodynamics